Investigational mRNA Vaccine Induced Persistent Immune Response in
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…
Michael Wang, MD, presents the primary analysis results from the multinational, randomized, double-blind, phase 3 SYMPATICO study comparing ibrutinib plus venetoclax vs ibrutinib plus placebo…
Experiencing guilt after cancer treatment may sound unexpected, but it’s actually quite common. Clinical psychologist Catherine Powers, Ph.D., and senior social work counselor Kendolyn Shankle…
New MSK research provides two examples of computational tools developed at MSK that leverage data about cells’ locations to expand our understanding of cancer.
Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS…
An abstract is unavailable.
Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, according to Ritu Salani, MD, MBA.
The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
Leland Metheny, MD, discusses ongoing clinical trials and their implications for the field of hematologic oncology.
Agencje rejestrujące leki, takie jak FDA czy EMA, mogą dopuszczać leki w procedurze przyspieszonej lub warunkowo. Bywa, że jeśli lek okaże się nieskuteczny, może zostać…